The MRDR reaches another milestone of recruiting more than 7,000 patients!
Sueh-li Lim's paper on Real-world outcomes in relapsed refractory multiple myeloma patients exposed to three or more prior treatments has been published.
The MRDR had the opportunity to for two poster presentations at the International Myeloma Society Annual meeting in Athens.
The MRDR reaches another milestone of recruiting more than 6500 patients!
Please join us for our annual Interest Group breakfast at Blood 2023, 6th November.
MY-PROMPT-2 project randomises first patient and enrols another!